Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcuity RM Group plc Regulatory News (ACRM)

Share Price Information for Acuity RM Group plc (ACRM)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.175 (-18.92%)
Bid:
0.70
Ask:
0.80
Spread: 0.10 (14.286%)
Market Cap: £1.83m
ACRM Live PriceLast checked at - London Stock Exchange

Intraday Acuity RM Group plc Share Chart

Grant of Options

26 Jun 2024 16:27

RNS Number : 0239U
Acuity RM Group PLC
26 June 2024
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

26 June 2024

 

Acuity RM Group plc

("Acuity" or the "Company")

Grant of Options

Acuity (AIM:ACRM), the software group, announces that, on 26 June 2024, the following share options were granted to directors and Persons Discharging Managerial Responsibilities (PDMRs) as detailed below: 

 

Name

Position

Options granted

Total number of options held

Angus Forrest

Executive Chair

3,002,564 *

3,802,564

Kerry Chambers

Chief Executive

2,251,922

2,251,922

Kate Buchan

Finance Director

1,125,961

1,125,961

Adam Freeman

Chief Technology Officer

750,641

750,641

 

The options have been granted under the Company's approved Enterprise Management Incentive share option scheme (the "EMI Scheme") and have an exercise price of 3.75 pence per share, the closing mid-market price of the shares, as derived from the AIM Appendix to the London Stock Exchange Daily Official List for 25 June 2024, (being the market price as defined under the rules of the EMI Scheme). Save for 1,501,282 options granted to Angus Forrest, the options are exercisable in whole or in part at any time in the next five years conditional on the market price (under the rules of the EMI Scheme) of the Company's shares reaching double the exercise price for a period of at least five consecutive trading days.

 

*1,501,282 of the options granted to Angus Forrest have been awarded as a reward for initiating, delivering and successfully integrating the acquisition of Acuity Risk Management Limited. These bonus options are not subject to any performance criteria and are exercisable between the first and tenth anniversaries of the date of grant.

 

The total number of options granted under the EMI Scheme is 7,131,088, representing approximately 4.75 per cent of the Company's current issued share capital. In addition, there are 1,600,000 unapproved share options. Accordingly, the total number of options that are outstanding is 8,731,088, representing approximately 5.82 per cent of the current issued share capital.

 

Enquiries:

Acuity RM Group Plc

www.acuityrmgroup.com

Angus Forrest, Executive Chair

020 3582 0566

W H Ireland (NOMAD and Broker)

www.whirelandcb.com

Mike Coe / Sarah Mather

 

Clear Capital Limited (Joint Broker)

Andrew Blaylock

 

020 7220 1666

 

 

020 3869 6080

Peterhouse Capital Limited (Joint broker)

Lucy Williams / Duncan Vasey

020 7469 0936

 

 

Note to Editors

Acuity RM Group plc

Acuity RM Group plc (AIM: ACRM), is an established provider of risk management services. Its award-winning STREAM® software platform collects data about organisations to improve business decisions and management. It is used by around 70 organisations in markets including government, utilities, defence, broadcasting, manufacturing and healthcare.

 

The Company is focused on delivering long term, sustainable growth in shareholder value. In the short to medium term this is expected to come from organic growth and thereafter may also come from complementary acquisitions.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Angus Forrest

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Chairman

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Acuity RM Group plc

b)

 

LEI

 

 

213800JHJFKALDJA5X97 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Share Options over Ordinary shares of 0.1p each

 

 GB00BR0WHY71

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

3.75p

3,002,564

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 n/a

 

 

 

e)

 

Date of the transaction

 

 

26 June 2024

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kerry Chambers

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive, Acuity Risk Management Ltd

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Acuity RM Group plc

b)

 

LEI

 

 

213800JHJFKALDJA5X97 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Share Options over Ordinary shares of 0.1p each

 

GB00BR0WHY71 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

3.75p

2,251,922

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

26 June 2024

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kate Buchan

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Finance Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Acuity RM Group plc

b)

 

LEI

 

 

213800JHJFKALDJA5X97 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Share Options over Ordinary shares of 0.1p each

 

 GB00BR0WHY71

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

3.75p

1,125,961

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

 n/a

 

e)

 

Date of the transaction

 

 

26 June 2024

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Adam Freeman

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Technology Officer, Acuity Risk Management Limited

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Acuity RM Group plc

b)

 

LEI

 

 

213800JHJFKALDJA5X97 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Share Options over Ordinary shares of 0.1p each

 

 GB00BR0WHY71

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

3.75p

750,641

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

e)

 

Date of the transaction

 

 

26 June 2024

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEQLFLZQLLBBQ
12
Date   Source Headline
17th Jun 20267:00 amPRNRetail Offer
16th Jun 20264:33 pmRNSFundraise of approximately £400,000
8th Jun 20267:00 amRNS-RContract Expansion
24th Apr 20267:00 amPRNTrading Statement
23rd Apr 20267:00 amPRNTrading Statement
27th Mar 20267:00 amPRNIssue of Equity
16th Mar 20267:00 amRNSProduct Launch
16th Mar 20267:00 amPRNProduct Launch
9th Mar 20267:00 amRNS-RA client’s experience of Acuity
24th Feb 20267:00 amRNS-RContract win
17th Feb 20267:00 amPRNContract
5th Feb 20262:35 pmPRNDirector/PDMR Shareholding
5th Feb 20261:17 pmPRNPDMR Shareholding
4th Feb 20267:00 amPRNHolding in Company
2nd Feb 20267:00 amPRNContract
15th Jan 20268:07 pmPRNHoldings in Company and Director Dealing
15th Jan 20267:00 amPRNStatement re Investor Presentation 10.00am 21 January
13th Jan 20267:00 amPRNTrading Statement
18th Nov 20258:47 amRNSHolding(s) in Company
17th Nov 20257:00 amPRNStatement re sale of investment
13th Nov 20254:06 pmPRNHolding(s) in Company
12th Nov 20257:00 amPRNDirectorate changes
21st Oct 20257:00 amRNS-RContract Win
7th Oct 20257:00 amPRNContract
22nd Sep 20257:00 amPRNIssue of Equity
16th Sep 20251:03 pmPRNHolding(s) in Company
5th Sep 20257:00 amPRNStatement re Investor presentation 10.00am 11 September
2nd Sep 20257:00 amPRNHalf-year Report
18th Aug 20257:00 amRNS-RFirst customer win for new product
30th Jul 20251:52 pmPRNResult of AGM
29th Jul 20257:00 amPRNIssue of Equity
11th Jul 202511:33 amPRNHolding(s) in Company
7th Jul 20254:09 pmPRNAnnual Report and Notice of AGM
7th Jul 202512:23 pmPRNHolding(s) in Company
7th Jul 20257:00 amPRNProduct Launch
4th Jul 202511:56 amPRNHolding(s) in Company
2nd Jul 20257:00 amPRNStatement re Final Results
30th Jun 20251:54 pmPRNIssue of Equity
26th Jun 20256:04 pmPRNHolding(s) in Company
25th Jun 20259:30 amRNSFinal Results
19th Jun 20253:22 pmPRNHolding(s) in Company
13th Jun 202510:30 amPRNStatement re Business and Directorate
21st May 20257:00 amPRNIssue of Equity
19th May 20259:45 amPRNIssue of Equity
19th May 20257:00 amPRNIssue of Equity
6th Mar 20257:00 amPRNStatement re Investor Presentation
17th Feb 20257:00 amPRNDirector/PDMR Shareholding
7th Feb 20257:00 amPRNChanges in share options
5th Feb 20258:59 amPRNCorrection to Year end Update
4th Feb 20257:00 amPRNTrading Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.